| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.02 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | 0.39 | 0.02 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |